To include your compound in the COVID-19 Resource Center, submit it here.

Can-Fite, Denali Concrete Management Inc. ophthalmic news

Can-Fite will grant an exclusive, worldwide sublicense to CF101 for ophthalmic indications to shell company

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE